NYU004.GS7.4 |
|
|
Sector |
Clonality |
Gleason
Score (Diagnostic
Biopsy) |
Percent
of core involvement by cancer |
Proportion
of
clonal cells per sector (clonal/sector total cells) |
|
|
1 |
yes |
GS 8 (4 + 4) |
20 |
5/23 |
|
|
2 |
yes |
GS 8 (4 + 4) |
90 |
19/24 |
|
|
3 |
no |
Benign |
0 |
0/23 |
|
|
4 |
no |
GS 8 (4 + 4) |
5 |
0/23 |
|
|
5 |
no |
GS 8 (4 + 4) |
<5 |
0/20 |
|
|
6 |
no |
Benign |
0 |
0/20 |
|
|
7 |
yes |
Benign |
0 |
8/23 |
|
|
8 |
no |
Benign |
0 |
0/23 |
|
|
9 |
no |
Benign |
0 |
0/23 |
|
|
10 |
no |
Benign |
0 |
0/24 |
|
|
11 |
no |
Benign |
0 |
0/22 |
|
|
12 |
no |
Benign |
0 |
0/23 |
|
|
13* |
yes |
GS 8 (4 + 4) |
100 |
17/21 |
|
|
14* |
yes |
GS 8 (4 + 4) |
80 |
2/22 |
|
|
|
|
Total clonal
cells/Total cells |
51/314 |
|
|
*Indicates MRI-ultrasound fusion targeted
biopsies. (&) Indicates percent of
core involved by carcinoma in most extensively involved core. Sector: Hyperlinks to copy number plots of representative cell, in vitro bulk and
in silico bulk samples
for the selected sector. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|